Recent studies show that Notch4 acts as an oncogene in some types of cancers, such as colorectal cancer (Wu et al., 2018), triple-negative breast cancer (Zhou et al., 2020), and prostate cancer (Zhang et al., 2017). This evidence concerns the gene NOTCH4 and cancer.